{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T14:28:18Z","timestamp":1769437698428,"version":"3.49.0"},"reference-count":125,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:00:00Z","timestamp":1750809600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"Association Strumpell-Lorrain"},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["NEURO-NGS3"],"award-info":[{"award-number":["NEURO-NGS3"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurogenetics"],"DOI":"10.1007\/s10048-025-00833-8","type":"journal-article","created":{"date-parts":[[2025,6,25]],"date-time":"2025-06-25T00:47:32Z","timestamp":1750812452000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Experience in the clinical and genetic diagnosis of a series of Algerian patients with hereditary spastic paraplegias"],"prefix":"10.1007","volume":"26","author":[{"given":"Mouna","family":"Messaoud-Khelifi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Razika","family":"Boulariah-Hadjou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohamed Islam","family":"Kediha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lena","family":"Guillot-Noel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marine","family":"Guillaud-Bataille","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christelle Marie","family":"Durand","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lamia","family":"Ali-Pacha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wahiba","family":"Amer El Khedoud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fanny","family":"Mochel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Madeleine","family":"de Sainte-Agathe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9368-8657","authenticated-orcid":false,"given":"Giovanni","family":"Stevanin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,6,25]]},"reference":[{"key":"833_CR1","doi-asserted-by":"publisher","unstructured":"Ruano L, Melo C, Silva MC, Coutinho P (2014) The global epidemiology of hereditary ataxia and spastic paraplegia: a systematic review of prevalence studies. Neuroepidemiology 42:174\u2013183. https:\/\/doi.org\/10.1159\/000358801","DOI":"10.1159\/000358801"},{"key":"833_CR2","doi-asserted-by":"publisher","unstructured":"Harding AE (1983) Classification of the hereditary ataxias and paraplegias. Lancet 321:1151\u20131155. https:\/\/doi.org\/10.1016\/S0140-6736(83)92879-9","DOI":"10.1016\/S0140-6736(83)92879-9"},{"key":"833_CR3","doi-asserted-by":"crossref","unstructured":"Murala S, Nagarajan E, Bollu PC (2021) Hereditary spastic paraplegia. Neurol Sci 42:883\u2013894. https:\/\/doi.10.1007\/s10072-020-04981-7","DOI":"10.1007\/s10072-020-04981-7"},{"key":"833_CR4","doi-asserted-by":"crossref","unstructured":"Fink JK (2023) The hereditary spastic paraplegias., In: Handbook of Clinical Neurology, Elsevier, pp. 59\u201388. https:\/\/doi.10.1016\/B978-0-323-98817-9.00022-3","DOI":"10.1016\/B978-0-323-98817-9.00022-3"},{"issue":"4","key":"833_CR5","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1007\/s11910-019-0930-2","volume":"19","author":"M Boutry","year":"2019","unstructured":"Boutry M, Morais S, Stevanin G (2019) Update on the genetics of spastic paraplegias. Curr Neurol Neurosci Rep 19(4):18. https:\/\/doi.org\/10.1007\/s11910-019-0930-2","journal-title":"Curr Neurol Neurosci Rep"},{"key":"833_CR6","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1002\/mdc3.12184","volume":"2","author":"KR Kumar","year":"2015","unstructured":"Kumar KR, Blair NF, Sue CM (2015) An update on the hereditary spastic paraplegias: new genes and new disease models. Mov Disord Clin Pract 2:213\u2013223. https:\/\/doi.org\/10.1002\/mdc3.12184","journal-title":"Mov Disord Clin Pract"},{"key":"833_CR7","doi-asserted-by":"publisher","unstructured":"Saputra L, Kumar KR (2021) Challenges and controversies in the genetic diagnosis of hereditary spastic paraplegia. Curr Neurol Neurosci Rep 21(15). https:\/\/doi.org\/10.1007\/s11910-021-01099-x","DOI":"10.1007\/s11910-021-01099-x"},{"key":"833_CR8","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/brain\/awab386","volume":"145","author":"J-L M\u00e9reaux","year":"2022","unstructured":"M\u00e9reaux J-L, Banneau G, Papin M, Coarelli G, Valter R, Raymond L et al (2022) Clinical and genetic spectra of 1550 index patients with hereditary spastic paraplegia. Brain 145:1029\u20131037. https:\/\/doi.org\/10.1093\/brain\/awab386","journal-title":"Brain"},{"key":"833_CR9","doi-asserted-by":"publisher","unstructured":"Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucl Acids Res 16:1215\u20131215. https:\/\/doi.org\/10.1093\/nar\/16.3.1215","DOI":"10.1093\/nar\/16.3.1215"},{"key":"833_CR10","doi-asserted-by":"publisher","unstructured":"Van der Auwera GA, Carneiro MO, Hartl C, Poplin R, Del Angel G, Levy-Moonshine A et al (2013) From FastQ data to high confidence variant calls: the Genome Analysis Toolkit best practices pipeline. Curr Protoc Bioinformatics 43:11.10.1\u201311.10.33. https:\/\/doi.org\/10.1002\/0471250953.bi1110s43","DOI":"10.1002\/0471250953.bi1110s43"},{"key":"833_CR11","doi-asserted-by":"crossref","unstructured":"Laurie S, Piscia D, Matalonga L, Corv\u00f3 A, Fern\u00e1ndez-Callejo M, Garcia-Linares C et al (2022) The RD-Connect Genome-Phenome Analysis Platform: Accelerating diagnosis, research, and gene discovery for rare diseases. Hum Mutat 43:717\u2013733. https:\/\/doi.10.1002\/humu.24353","DOI":"10.1002\/humu.24353"},{"key":"833_CR12","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nature11690","volume":"493","author":"W Fu","year":"2013","unstructured":"Fu W, O\u2019Connor TD, Jun G, Kang HM, Abecasis G, Leal SM et al (2013) Analysis of 6,515 exomes reveals the recent origin of most human protein-coding variants. Nature 493:216\u2013220. https:\/\/doi.org\/10.1038\/nature11690","journal-title":"Nature"},{"key":"833_CR13","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1002\/humu.24309","volume":"43","author":"S Gudmundsson","year":"2022","unstructured":"Gudmundsson S, Singer-Berk M, Watts NA, Phu W, Goodrich JK, Solomonson M et al (2022) Variant interpretation using population databases: lessons from GnomAD. Hum Mutat 43:1012\u20131030. https:\/\/doi.org\/10.1002\/humu.24309","journal-title":"Hum Mutat"},{"key":"833_CR14","doi-asserted-by":"crossref","unstructured":"Cingolani P, Platts A, Wang LL, Coon M, Nguyen T, Wang L et al (2012) A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6:80\u201392. https:\/\/doi.10.4161\/fly.19695","DOI":"10.4161\/fly.19695"},{"key":"833_CR15","doi-asserted-by":"publisher","unstructured":"Landrum MJ, Chitipiralla S, Brown GR, Chen C, Gu B, Hart J et al (2020) ClinVar: improvements to accessing data. Nucleic Acids Res 48(D835\u2013D844). https:\/\/doi.org\/10.1093\/nar\/gkz972","DOI":"10.1093\/nar\/gkz972"},{"key":"833_CR16","doi-asserted-by":"crossref","unstructured":"Kircher M, Witten DM, Jain P, O\u2019Roak BJ, Cooper GM, Shendure J (2014) A general framework for estimating the relative pathogenicity of human genetic variants. Nat Genet 46:310\u2013315. https:\/\/doi.10.1038\/ng.2892","DOI":"10.1038\/ng.2892"},{"key":"833_CR17","doi-asserted-by":"crossref","unstructured":"Adzhubei I, Jordan DM, Sunyaev SR (2013) Predicting functional effect of human missense mutations using PolyPhen-2. Curr Protoc Hum Genet Chap. 7 Unit7.20. https:\/\/doi.10.1002\/0471142905.hg0720s76","DOI":"10.1002\/0471142905.hg0720s76"},{"key":"833_CR18","doi-asserted-by":"crossref","unstructured":"Vaser R, Adusumalli S, Leng SN, Sikic M, Ng PC (2016) SIFT missense predictions for genomes. Nat Protoc 11:1\u20139. https:\/\/doi.10.1038\/nprot.2015.123","DOI":"10.1038\/nprot.2015.123"},{"key":"833_CR19","doi-asserted-by":"publisher","first-page":"W446","DOI":"10.1093\/nar\/gkab266","volume":"49","author":"R Steinhaus","year":"2021","unstructured":"Steinhaus R, Proft S, Schuelke M, Cooper DN, Schwarz JM, Seelow D (2021) MutationTaster2021. Nucleic Acids Res 49:W446\u2013W451. https:\/\/doi.org\/10.1093\/nar\/gkab266","journal-title":"Nucleic Acids Res"},{"key":"833_CR20","doi-asserted-by":"crossref","unstructured":"Jaganathan K, Kyriazopoulou Panagiotopoulou S, McRae JF, Darbandi SF, Knowles D, Li YI et al (2019) Predicting Splicing from Primary Sequence with Deep Learning. Cell 176:535\u2013548.e24. https:\/\/doi.10.1016\/j.cell.2018.12.015","DOI":"10.1016\/j.cell.2018.12.015"},{"key":"833_CR21","doi-asserted-by":"publisher","unstructured":"Zeng T, Li YI (2022) Predicting RNA splicing from DNA sequence using Pangolin. Genome Biol 23(103). https:\/\/doi.org\/10.1186\/s13059-022-02664-4","DOI":"10.1186\/s13059-022-02664-4"},{"key":"833_CR22","doi-asserted-by":"crossref","unstructured":"den Dunnen JT, Dalgleish R, Maglott DR, Hart RK, Greenblatt MS, McGowan-Jordan J et al (2016) HGVS Recommendations for the Description of Sequence Variants: 2016 Update. Hum Mutat 37:564\u2013569. https:\/\/doi.10.1002\/humu.22981","DOI":"10.1002\/humu.22981"},{"key":"833_CR23","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/gim.2015.30","volume":"17","author":"S Richards","year":"2015","unstructured":"Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J et al (2015) Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American college of medical genetics and genomics and the association for molecular pathology. Genet Med 17:405\u2013424. https:\/\/doi.org\/10.1038\/gim.2015.30","journal-title":"Genet Med"},{"key":"833_CR24","doi-asserted-by":"crossref","unstructured":"Zhao X, Alvarado D, Rainier S, Lemons R, Hedera P, Weber CH et al (2001) Mutations in a newly identified GTPase gene cause autosomal dominant hereditary spastic paraplegia. Nat Genet 29:326\u2013331. https:\/\/doi.10.1038\/ng758","DOI":"10.1038\/ng758"},{"key":"833_CR25","doi-asserted-by":"crossref","unstructured":"Kadnikova VA, Rudenskaya GE, Stepanova AA, Sermyagina IG, Ryzhkova OP (2019) Mutational Spectrum of Spast (Spg4) and Atl1 (Spg3a) Genes In Russian Patients With Hereditary Spastic Paraplegia. Sci Rep 9:14412. https:\/\/doi.10.1038\/s41598-019-50911-9","DOI":"10.1038\/s41598-019-50911-9"},{"key":"833_CR26","doi-asserted-by":"crossref","unstructured":"Schuurs-Hoeijmakers JHM, Geraghty MT, Kamsteeg E-J, Ben-Salem S, de Bot ST, Nijhof B et al (2012) Mutations in DDHD2, encoding an intracellular phospholipase A(1), cause a recessive form of complex hereditary spastic paraplegia. Am J Hum Genet 91:1073\u20131081. https:\/\/doi.10.1016\/j.ajhg.2012.10.017","DOI":"10.1016\/j.ajhg.2012.10.017"},{"key":"833_CR27","doi-asserted-by":"publisher","first-page":"567","DOI":"10.3389\/fneur.2017.00567","volume":"8","author":"A Bouhouche","year":"2017","unstructured":"Bouhouche A, Tesson C, Regragui W, Rahmani M, Drouet V, Tibar H et al (2017) Mutation analysis of consanguineous Moroccan patients with parkinson\u2019s disease combining microarray and gene panel. Front Neurol 8:567. https:\/\/doi.org\/10.3389\/fneur.2017.00567","journal-title":"Front Neurol"},{"key":"833_CR28","doi-asserted-by":"crossref","unstructured":"Tessa A, Battini R, Rubegni A, Storti E, Marini C, Galatolo D et al (2016) Identification of mutations in AP4S1\/SPG52 through next generation sequencing in three families. Eur J Neurol 23:1580\u20131587. https:\/\/doi.10.1111\/ene.13085","DOI":"10.1111\/ene.13085"},{"key":"833_CR29","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1007\/s00415-016-8066-7","volume":"263","author":"L Leonardi","year":"2016","unstructured":"Leonardi L, Ziccardi L, Marcotulli C, Rubegni A, Longobardi A, Serrao M et al (2016) Pigmentary degenerative maculopathy as prominent phenotype in an Italian SPG56\/CYP2U1 family. J Neurol 263:781\u2013783. https:\/\/doi.org\/10.1007\/s00415-016-8066-7","journal-title":"J Neurol"},{"key":"833_CR30","doi-asserted-by":"crossref","unstructured":"Verkerk AJMH, Schot R, Dumee B, Schellekens K, Swagemakers S, Bertoli-Avella AM et al (2009) Mutation in the AP4M1 gene provides a model for neuroaxonal injury in cerebral palsy. Am J Hum Genet 85:40\u201352. https:\/\/doi.10.1016\/j.ajhg.2009.06.004","DOI":"10.1016\/j.ajhg.2009.06.004"},{"key":"833_CR31","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1038\/ng1980","volume":"39","author":"G Stevanin","year":"2007","unstructured":"Stevanin G, Santorelli FM, Azzedine H, Coutinho P, Chomilier J, Denora PS et al (2007) Mutations in SPG11, encoding spatacsin, are a major cause of spastic paraplegia with thin corpus callosum. Nat Genet 39:366\u2013372. https:\/\/doi.org\/10.1038\/ng1980","journal-title":"Nat Genet"},{"key":"833_CR32","doi-asserted-by":"crossref","unstructured":"Elsayed LEO, Eltazi IZ, Ahmed AE, Stevanin G (2021) Insights into Clinical, Genetic, and Pathological Aspects of Hereditary Spastic Paraplegias: A Comprehensive Overview. Front Mol Biosci 8:690899. https:\/\/doi.10.3389\/fmolb.2021.690899","DOI":"10.3389\/fmolb.2021.690899"},{"key":"833_CR33","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s10048-023-00717-9","volume":"24","author":"D Galatolo","year":"2023","unstructured":"Galatolo D, Trovato R, Scarlatti A, Rossi S, Natale G, De Michele G et al (2023) Power of NGS-based tests in HSP diagnosis: analysis of massively parallel sequencing in clinical practice. Neurogenetics 24:147\u2013160. https:\/\/doi.org\/10.1007\/s10048-023-00717-9","journal-title":"Neurogenetics"},{"key":"833_CR34","doi-asserted-by":"publisher","first-page":"153","DOI":"10.18231\/j.ijcbr.2021.034","volume":"8","author":"G Gawade","year":"2021","unstructured":"Gawade G, Chaudhary SA, Chaudhary S, Rawat S, Bilgrami AL, Padwal M (2021) Next generation sequencing: A promising tool to explore the personalized medicine in Understanding the neurodegenerative diseases. IJCBR 8:153\u2013162. https:\/\/doi.org\/10.18231\/j.ijcbr.2021.034","journal-title":"IJCBR"},{"key":"833_CR35","doi-asserted-by":"crossref","unstructured":"Valencia CA, Husami A, Holle J, Johnson JA, Qian Y, Mathur A et al (2015) Clinical Impact and Cost-Effectiveness of Whole Exome Sequencing as a Diagnostic Tool: A Pediatric Center\u2019s Experience. Front Pediatr 3:67. https:\/\/doi.10.3389\/fped.2015.00067","DOI":"10.3389\/fped.2015.00067"},{"key":"833_CR36","doi-asserted-by":"crossref","unstructured":"Dong Y, Li X-Y, Wang X-L, Xu F, Wang Z-J, Song Y et al (2021) Genetic, clinical and neuroimaging profiles of sporadic and autosomal recessive hereditary spastic paraplegia cases in Chinese. Neurosci Lett 761:136108. https:\/\/doi.10.1016\/j.neulet.2021.136108","DOI":"10.1016\/j.neulet.2021.136108"},{"key":"833_CR37","doi-asserted-by":"publisher","first-page":"1529","DOI":"10.1007\/s13760-021-01779-y","volume":"122","author":"I Sahin","year":"2022","unstructured":"Sahin I, Saat H (2022) Hereditary spastic paraplegia: new insights into clinical variability and spasticity-ataxia phenotype, and novel mutations. Acta Neurol Belg 122:1529\u20131535. https:\/\/doi.org\/10.1007\/s13760-021-01779-y","journal-title":"Acta Neurol Belg"},{"key":"833_CR38","doi-asserted-by":"crossref","unstructured":"Balicza P, Grosz Z, Gonzalez MA, Bencsik R, Pentelenyi K, Gal A et al (2016) Genetic background of the hereditary spastic paraplegia phenotypes in Hungary - An analysis of 58 probands. J Neurol Sci 364:116\u2013121. https:\/\/doi.10.1016\/j.jns.2016.03.018","DOI":"10.1016\/j.jns.2016.03.018"},{"key":"833_CR39","doi-asserted-by":"crossref","unstructured":"Kancheva D, Atkinson D, De Rijk P, Zimon M, Chamova T, Mitev V et al (2016) Novel mutations in genes causing hereditary spastic paraplegia and Charcot-Marie-Tooth neuropathy identified by an optimized protocol for homozygosity mapping based on whole-exome sequencing. Genet Med 18:600\u2013607. https:\/\/doi.10.1038\/gim.2015.139","DOI":"10.1038\/gim.2015.139"},{"key":"833_CR40","doi-asserted-by":"crossref","unstructured":"Schiavoni S, Spagnoli C, Rizzi S, Salerno GG, Frattini D, Pisani F et al (2020) Paediatric-onset hereditary spastic paraplegias: a retrospective cohort study. Dev Med Child Neurol 62:1068\u20131074. https:\/\/doi.10.1111\/dmcn.14547","DOI":"10.1111\/dmcn.14547"},{"key":"833_CR41","doi-asserted-by":"crossref","unstructured":"Yang JO, Yoon J-Y, Sung DH, Yun S, Lee J-J, Jun SY et al (2021) The emerging genetic diversity of hereditary spastic paraplegia in Korean patients. Genomics 113:4136\u20134148. https:\/\/doi.10.1016\/j.ygeno.2021.10.014","DOI":"10.1016\/j.ygeno.2021.10.014"},{"key":"833_CR42","doi-asserted-by":"crossref","unstructured":"Ikeda A, Kumaki T, Tsuyusaki Y, Tsuji M, Enomoto Y, Fujita A et al (2023) Genetic and clinical features of pediatric-onset hereditary spastic paraplegia: a single-center study in Japan. Front Neurol 14:1085228. https:\/\/doi.10.3389\/fneur.2023.1085228","DOI":"10.3389\/fneur.2023.1085228"},{"key":"833_CR43","doi-asserted-by":"crossref","unstructured":"Kara E, Tucci A, Manzoni C, Lynch DS, Elpidorou M, Bettencourt C et al (2016) Genetic and phenotypic characterization of complex hereditary spastic paraplegia. Brain 139:1904\u20131918. https:\/\/doi.10.1093\/brain\/aww111","DOI":"10.1093\/brain\/aww111"},{"key":"833_CR44","doi-asserted-by":"crossref","unstructured":"Sch\u00fcle R, Wiethoff S, Martus P, Karle KN, Otto S, Klebe S et al (2016) Hereditary spastic paraplegia: Clinicogenetic lessons from 608 patients. Ann Neurol 79:646\u2013658. https:\/\/doi.10.1002\/ana.24611","DOI":"10.1002\/ana.24611"},{"key":"833_CR45","doi-asserted-by":"crossref","unstructured":"D\u2019Amore A, Tessa A, Casali C, Dotti MT, Filla A, Silvestri G et al (2018) Next generation molecular diagnosis of hereditary spastic paraplegias: an Italian cross-sectional study. Front Neurol 9:981. https:\/\/doi.10.3389\/fneur.2018.00981","DOI":"10.3389\/fneur.2018.00981"},{"key":"833_CR46","first-page":"289","volume":"12","author":"S Zaoui","year":"2002","unstructured":"Zaoui S, Bi\u00e9mont C (2002) [Frequency of consanguineous unions in the Tlemcen area (West Algeria)]. Sante 12:289\u2013295","journal-title":"Sante"},{"key":"833_CR47","unstructured":"Sidi-Yakhlef A, Metri AA (2013) Etude Anthropo-sociologique de La consanguinit\u00e9 Dans La population de Oulha\u00e7a Dans l\u2019ouest Alg\u00e9rien. Anthropologie 45\u201359"},{"key":"833_CR48","first-page":"457","volume":"9","author":"M Guidoum","year":"2015","unstructured":"Guidoum M, Kefi R, Abdelhak S, Bouslama Z (2015) Consanguinity and endogamy of a Northeastern Algerian population (population of El-Kala). Adv Environ Biology 9:457\u2013465","journal-title":"Adv Environ Biology"},{"key":"833_CR49","first-page":"403","volume":"9","author":"S Saoudi","year":"2015","unstructured":"Saoudi S, Ben-Halim N, Kefi R, Abdelhak S, Bouslama Z (2015) Consanguinity and homogamous marriages among chaouis, a Berber population from Eastern Algeria. Adv Environ Biology 9:403\u2013408","journal-title":"Adv Environ Biology"},{"key":"833_CR50","doi-asserted-by":"crossref","unstructured":"Bachir S, Aouar A (2019) Study of the impact of consanguinity on abortion and mortality in the population of Beni Abbes (southwestern Algeria). Egypt J Med Hum Genet 20:1. https:\/\/doi.10.1186\/s43042-019-0004-7","DOI":"10.1186\/s43042-019-0004-7"},{"key":"833_CR51","doi-asserted-by":"crossref","unstructured":"Travaglini L, Aiello C, Stregapede F, D\u2019Amico A, Alesi V, Ciolfi A et al (2018) The impact of next-generation sequencing on the diagnosis of pediatric-onset hereditary spastic paraplegias: new genotype-phenotype correlations for rare HSP-related genes. Neurogenetics 19:111\u2013121. https:\/\/doi.10.1007\/s10048-018-0545-9","DOI":"10.1007\/s10048-018-0545-9"},{"key":"833_CR52","doi-asserted-by":"crossref","unstructured":"Boukhris A, Stevanin G, Feki I, Denora P, Elleuch N, Miladi M et al (2009) Tunisian hereditary spastic paraplegias: clinical variability supported by genetic heterogeneity. Clinical Genetics 75:527\u2013536. https:\/\/doi.10.1111\/j.1399-0004.2009.01176.x","DOI":"10.1111\/j.1399-0004.2009.01176.x"},{"key":"833_CR53","doi-asserted-by":"crossref","unstructured":"Koul R, Al-Murshedi FM, Al-Azri FM, Mani R, Abdelrahim RA, Koul V et al (2013) Clinical spectrum of hereditary spastic paraplegia in children: a study of 74 cases. Sultan Qaboos Univ Med J 13:371\u2013379. https:\/\/doi.10.12816\/0003258","DOI":"10.18295\/2075-0528.1491"},{"key":"833_CR54","doi-asserted-by":"crossref","unstructured":"Elsayed LEO, Mohammed IN, Hamed AAA, Elseed MA, Johnson A, Mairey M et al (2016) Hereditary spastic paraplegias: identification of a novel SPG57 variant affecting TFG oligomerization and description of HSP subtypes in Sudan. Eur J Hum Genet 25:100\u2013110. https:\/\/doi.10.1038\/ejhg.2016.108","DOI":"10.1038\/ejhg.2016.108"},{"key":"833_CR55","doi-asserted-by":"crossref","unstructured":"Yahia A, Hamed AAA, Mohamed IN, Elseed MA, Salih MA, El-Sadig SM et al (2023) Clinical phenotyping and genetic diagnosis of a large cohort of Sudanese families with hereditary spinocerebellar degenerations. Eur J Hum Genet 32(10):1214\u20131226. https:\/\/doi.10.1038\/s41431-023-01344-6","DOI":"10.1038\/s41431-023-01344-6"},{"key":"833_CR56","doi-asserted-by":"crossref","unstructured":"Ak\u00e7akaya NH, \u00d6ze\u015f Ak B, Gonzalez MA, Z\u00fcchner S, Battalo\u011flu E, Parman Y (2020) Clinical and genetic aspects of hereditary spastic paraplegia in patients from Turkey. Neurol Neurochir Pol 54:176\u2013184. https:\/\/doi.10.5603\/PJNNS.a2020.0026","DOI":"10.5603\/PJNNS.a2020.0026"},{"key":"833_CR57","doi-asserted-by":"crossref","unstructured":"Coutinho P, Barros J, Zemmouri R, Guimar\u00e3es J, Alves C, Chor\u00e3o R et al (1999) Clinical heterogeneity of autosomal recessive spastic paraplegias: analysis of 106 patients in 46 families. Arch Neurol 56:943. https:\/\/doi.10.1001\/archneur.56.8.943","DOI":"10.1001\/archneur.56.8.943"},{"key":"833_CR58","doi-asserted-by":"crossref","unstructured":"Pozner T, Regensburger M, Engelhorn T, Winkler J, Winner B (2020) Janus-faced spatacsin (SPG11): involvement in neurodevelopment and multisystem neurodegeneration. Brain 143:2369\u20132379. https:\/\/doi.10.1093\/brain\/awaa099","DOI":"10.1093\/brain\/awaa099"},{"key":"833_CR59","doi-asserted-by":"crossref","unstructured":"Hehr U, Bauer P, Winner B, Schule R, Olmez A, Koehler W et al (2007) Long-term course and mutational spectrum of spatacsin\u2010linked spastic paraplegia. Annals of Neurology 62:656\u2013665. https:\/\/doi.10.1002\/ana.21310","DOI":"10.1002\/ana.21310"},{"key":"833_CR60","doi-asserted-by":"crossref","unstructured":"Boukhris A, Stevanin G, Feki I, Denis E, Elleuch N, Miladi MI et al (2008) Hereditary spastic paraplegia with mental impairment and thin corpus callosum in Tunisia: SPG11, SPG15, and further genetic heterogeneity. Arch Neurol 65:(3):393\u2013402. https:\/\/doi.10.1001\/archneur.65.3.393","DOI":"10.1001\/archneur.65.3.393"},{"key":"833_CR61","doi-asserted-by":"crossref","unstructured":"Yoon WT, Lee WY, Lee S-T, Ahn JY, Ki C-S, Cho JW (2012) Atypical hereditary spastic paraplegia with thin corpus callosum in a Korean patient with a novel SPG11 mutation. Eur J Neurol 19:e7-8. https:\/\/doi.10.1111\/j.1468-1331.2011.03569.x","DOI":"10.1111\/j.1468-1331.2011.03569.x"},{"key":"833_CR62","doi-asserted-by":"crossref","unstructured":"Fran\u00e7a MC, Yasuda CL, Pereira FRS, D\u2019Abreu A, Lopes-Ramos CM, Rosa MV et al (2012) White and grey matter abnormalities in patients with SPG11 mutations. J Neurol Neurosurg Psychiatry 83:828\u2013833. https:\/\/doi.10.1136\/jnnp-2011-300129","DOI":"10.1136\/jnnp-2011-300129"},{"key":"833_CR63","doi-asserted-by":"crossref","unstructured":"Pensato V, Castellotti B, Gellera C, Pareyson D, Ciano C, Nanetti L et al (2014) Overlapping phenotypes in complex spastic paraplegias SPG11, SPG15, SPG35 and SPG48. Brain 137:1907\u20131920. https:\/\/doi.10.1093\/brain\/awu121","DOI":"10.1093\/brain\/awu121"},{"key":"833_CR64","doi-asserted-by":"crossref","unstructured":"G\u00fcnther S, Elert-Dobkowska E, Soehn AS, Hinreiner S, Yoon G, Heller R et al (2016) High Frequency of Pathogenic Rearrangements in SPG11 and Extensive Contribution of Mutational Hotspots and Founder Alleles. Hum Mutat 37:703\u2013709. https:\/\/doi.10.1002\/humu.23000","DOI":"10.1002\/humu.23000"},{"key":"833_CR65","doi-asserted-by":"crossref","unstructured":"Morais S, Raymond L, Mairey M, Coutinho P, Brand\u00e3o E, Ribeiro P et al (2017) Massive sequencing of 70 genes reveals a myriad of missing genes or mechanisms to be uncovered in hereditary spastic paraplegias. Eur J Hum Genet 25:1217\u20131228. https:\/\/doi.10.1038\/ejhg.2017.124","DOI":"10.1038\/ejhg.2017.124"},{"key":"833_CR66","doi-asserted-by":"crossref","unstructured":"Elert-Dobkowska E, Stepniak I, Krysa W, Ziora-Jakutowicz K, Rakowicz M, Sobanska A et al (2019) Next-generation sequencing study reveals the broader variant spectrum of hereditary spastic paraplegia and related phenotypes. Neurogenetics 20:27\u201338. https:\/\/doi.10.1007\/s10048-019-00565-6","DOI":"10.1007\/s10048-019-00565-6"},{"key":"833_CR67","doi-asserted-by":"crossref","unstructured":"Wei Q, Dong H-L, Pan L-Y, Chen C-X, Yan Y-T, Wang R-M et al (2019) Clinical features and genetic spectrum in Chinese patients with recessive hereditary spastic paraplegia. Transl Neurodegener 8:19. https:\/\/doi.10.1186\/s40035-019-0157-9","DOI":"10.1186\/s40035-019-0157-9"},{"key":"833_CR68","doi-asserted-by":"crossref","unstructured":"Kunta AR, Jueng J, Jordan C, Kojic J, Mo A, Ebrahimi-Fakhari D (2022) Blended phenotype of prader-willi syndrome and HSP-SPG11 caused by maternal uniparental isodisomy. Neurol Genet 8:e200041. https:\/\/doi.10.1212\/NXG.0000000000200041","DOI":"10.1212\/NXG.0000000000200041"},{"key":"833_CR69","doi-asserted-by":"crossref","unstructured":"Orl\u00e9n H, Melberg A, Raininko R, Kumlien E, Entesarian M, S\u00f6derberg P et al (2009) SPG11 mutations cause Kjellin syndrome, a hereditary spastic paraplegia with thin corpus callosum and central retinal degeneration. Am J Med Genet B Neuropsychiatr Genet 150B:984\u2013992. https:\/\/doi.10.1002\/ajmg.b.30928","DOI":"10.1002\/ajmg.b.30928"},{"key":"833_CR70","doi-asserted-by":"crossref","unstructured":"Stevanin G, Azzedine H, Denora P, Boukhris A, Tazir M, Lossos A et al (2008) Mutations in SPG11 are frequent in autosomal recessive spastic paraplegia with thin corpus callosum, cognitive decline and lower motor neuron degeneration. Brain 131:772\u2013784. https:\/\/doi.10.1093\/brain\/awm293","DOI":"10.1093\/brain\/awm293"},{"key":"833_CR71","doi-asserted-by":"crossref","unstructured":"Crimella C, Arnoldi A, Crippa F, Mostacciuolo ML, Boaretto F, Sironi M et al (2009) Point mutations and a large intragenic deletion in SPG11 in complicated spastic paraplegia without thin corpus callosum. J Med Genet 46:345\u2013351. https:\/\/doi.10.1136\/jmg.2008.063321","DOI":"10.1136\/jmg.2008.063321"},{"key":"833_CR72","doi-asserted-by":"crossref","unstructured":"Doleckova K, Roth J, Stellmachova J, Gescheidt T, Sigut V, Houska P et al (2022) SPG11: clinical and genetic features of seven Czech patients and literature review. Neurol Res 44:379\u2013389. https:\/\/doi.10.1080\/01616412.2021.1975224","DOI":"10.1080\/01616412.2021.1975224"},{"key":"833_CR73","doi-asserted-by":"crossref","unstructured":"Utz KS, Kohl Z, Marterstock DC, Doerfler A, Winkler J, Schmidt M et al (2022) Neuropsychology and MRI correlates of neurodegeneration in SPG11 hereditary spastic paraplegia. Orphanet J Rare Dis 17:301. https:\/\/doi.10.1186\/s13023-022-02451-1","DOI":"10.1186\/s13023-022-02451-1"},{"key":"833_CR74","doi-asserted-by":"crossref","unstructured":"Nakamura A, Izumi K, Umehara F, Kuriyama M, Hokezu Y, Nakagawa M et al (1995) Familial spastic paraplegia with mental impairment and thin corpus callosum. Journal of the Neurological Sciences 131:35\u201342. https:\/\/doi.10.1016\/0022-510X(95)00028-Z","DOI":"10.1016\/0022-510X(95)00028-Z"},{"key":"833_CR75","doi-asserted-by":"crossref","unstructured":"Sperfeld A-D, Kassubek J, Crosby AH, Winner B, Ludolph AC, Uttner I et al (2004) Complicated hereditary spastic paraplegia with thin corpus callosum: Variation of phenotypic expression over time. J Neurol 251:1285\u20131287. https:\/\/doi.10.1007\/s00415-004-0562-5","DOI":"10.1007\/s00415-004-0562-5"},{"key":"833_CR76","doi-asserted-by":"crossref","unstructured":"Casali C, Valente EM, Bertini E, Montagna G, Criscuolo C, De Michele G et al (2004) Clinical and genetic studies in hereditary spastic paraplegia with thin corpus callosum. Neurology 62:262\u2013268. https:\/\/doi.10.1212\/WNL.62.2.262","DOI":"10.1212\/WNL.62.2.262"},{"key":"833_CR77","doi-asserted-by":"crossref","unstructured":"Hourani R, El-Hajj T, Barada WH, Hourani M, Yamout BI (2009) MR imaging findings in autosomal recessive hereditary spastic paraplegia. AJNR Am J Neuroradiol 30:936\u2013940. https:\/\/doi.10.3174\/ajnr.A1483","DOI":"10.3174\/ajnr.A1483"},{"key":"833_CR78","doi-asserted-by":"crossref","unstructured":"Branchu J, Boutry M, Sourd L, Depp M, Leone C, Corriger A et al (2017) Loss of spatacsin function alters lysosomal lipid clearance leading to upper and lower motor neuron degeneration. Neurobiol Dis 102:21\u201337. https:\/\/doi.10.1016\/j.nbd.2017.02.007","DOI":"10.1016\/j.nbd.2017.02.007"},{"key":"833_CR79","doi-asserted-by":"crossref","unstructured":"Husain RA, Grimmel M, Wagner M, Hennings JC, Marx C, Feichtinger RG et al (2020) Bi-allelic HPDL variants cause a neurodegenerative disease ranging from neonatal encephalopathy to adolescent-onset spastic paraplegia. Am J Hum Genet 107:364\u2013373. https:\/\/doi.10.1016\/j.ajhg.2020.06.015","DOI":"10.1016\/j.ajhg.2020.06.015"},{"key":"833_CR80","unstructured":"Wiessner M, Maroofian R, Ni M-Y, Pedroni A, M\u00fcller JS, Stucka R et al (2021) Biallelic variants in HPDL cause pure and complicated hereditary spastic paraplegia. Brain 144:1422\u20131434. https:\/\/doi.10.1093\/brain\/awab041"},{"key":"833_CR81","doi-asserted-by":"crossref","unstructured":"Ghosh SG, Lee S, Fabunan R, Chai G, Zaki MS, Abdel-Salam G et al (2021) Biallelic variants in HPDL, encoding 4-hydroxyphenylpyruvate dioxygenase-like protein, lead to an infantile neurodegenerative condition. Genet Med 23:524\u2013533. https:\/\/doi.10.1038\/s41436-020-01010-y","DOI":"10.1038\/s41436-020-01010-y"},{"key":"833_CR82","doi-asserted-by":"crossref","unstructured":"Kojima F, Okamoto Y, Ando M, Higuchi Y, Hobara T, Yuan J et al (2024) A novel homozygous HPDL variant in Japanese siblings with autosomal recessive hereditary spastic paraplegia: case report and literature review. Neurogenetics 25:149\u2013156. https:\/\/doi.10.1007\/s10048-024-00746-y","DOI":"10.1007\/s10048-024-00746-y"},{"key":"833_CR83","doi-asserted-by":"crossref","unstructured":"Sun Y, Wei X, Fang F, Shen Y, Wei H, Li J et al (2021) HPDL deficiency causes a neuromuscular disease by impairing the mitochondrial respiration. J Genet Genomics 48:727\u2013736. https:\/\/doi.10.1016\/j.jgg.2021.01.009","DOI":"10.1016\/j.jgg.2021.01.009"},{"key":"833_CR84","doi-asserted-by":"crossref","unstructured":"Yu H, Wei Q, Luo W-J, Wu Z-Y (2021) Novel bi-allelic HPDL variants cause hereditary spastic paraplegia in a Chinese patient. Clin Genet 100:777\u2013778. https:\/\/doi.10.1111\/cge.14056","DOI":"10.1111\/cge.14056"},{"key":"833_CR85","doi-asserted-by":"crossref","unstructured":"Deng R, Medico-Salsench E, Nikoncuk A, Ramakrishnan R, Lanko K, K\u00fchn NA et al (2023) AMFR dysfunction causes autosomal recessive spastic paraplegia in human that is amenable to statin treatment in a preclinical model. Acta Neuropathol 146:353\u2013368. https:\/\/doi.10.1007\/s00401-023-02579-9","DOI":"10.1007\/s00401-023-02579-9"},{"key":"833_CR86","doi-asserted-by":"crossref","unstructured":"Ptok J, M\u00fcller L, Theiss S, Schaal H (2019) Context matters: Regulation of splice donor usage. Biochimica et Biophysica Acta (BBA) - Gene Regulatory Mechanisms 1862:194391. https:\/\/doi.10.1016\/j.bbagrm.2019.06.002","DOI":"10.1016\/j.bbagrm.2019.06.002"},{"key":"833_CR87","doi-asserted-by":"crossref","unstructured":"Lo Giudice T, Lombardi F, Santorelli FM, Kawarai T, Orlacchio A (2014) Hereditary spastic paraplegia: clinical-genetic characteristics and evolving molecular mechanisms. Exp Neurol 261:518\u2013539. https:\/\/doi.10.1016\/j.expneurol.2014.06.011","DOI":"10.1016\/j.expneurol.2014.06.011"},{"key":"833_CR88","doi-asserted-by":"crossref","unstructured":"de Souza PVS, de Rezende Pinto WBV, de Rezende Batistella GN, Bortholin T, Oliveira ASB (2017) Hereditary Spastic Paraplegia: Clinical and Genetic Hallmarks. Cerebellum 16:525\u2013551. https:\/\/doi.10.1007\/s12311-016-0803-z","DOI":"10.1007\/s12311-016-0803-z"},{"key":"833_CR89","doi-asserted-by":"crossref","unstructured":"Panza E, Meyyazhagan A, Orlacchio A (2022) Hereditary spastic paraplegia: Genetic heterogeneity and common pathways. Exp Neurol 357:114203. https:\/\/doi.10.1016\/j.expneurol.2022.114203","DOI":"10.1016\/j.expneurol.2022.114203"},{"key":"833_CR90","doi-asserted-by":"publisher","unstructured":"Wilkinson PA, Hart PE, Patel H, Warner TT, Crosby AH (2003) SPG3A mutation screening in English families with early onset autosomal dominant hereditary spastic paraplegia. Journal of the Neurological Sciences 216:43\u201345. https:\/\/doi.org\/10.1016\/S0022-510X(03)00210-7","DOI":"10.1016\/S0022-510X(03)00210-7"},{"key":"833_CR91","doi-asserted-by":"crossref","unstructured":"Sauter SM, Engel W, Neumann LM, Kunze J, Neesen J (2004) Novel mutations in theAtlastin gene (SPG3A) in families with autosomal dominant hereditary spastic paraplegia and evidence for late onset forms of HSP linked to theSPG3A locus. Hum Mutat 23:98\u201398. https:\/\/doi.10.1002\/humu.9205","DOI":"10.1002\/humu.9205"},{"key":"833_CR92","doi-asserted-by":"crossref","unstructured":"Namekawa M, Nelson I, Ribai P, D\u00fcrr A, Denis E, Stevanin G et al (2006) A founder effect and mutational hot spots may contribute to the most frequent mutations in the SPG3A gene. Neurogenetics 7:131\u2013132. https:\/\/doi.10.1007\/s10048-006-0028-2","DOI":"10.1007\/s10048-006-0028-2"},{"key":"833_CR93","doi-asserted-by":"crossref","unstructured":"Ivanova N, Claeys KG, Deconinck T, Litvinenko I, Jordanova A, Auer-Grumbach M et al (2007) Hereditary spastic paraplegia 3A associated with axonal neuropathy. Arch Neurol 64:706. https:\/\/doi.10.1001\/archneur.64.5.706","DOI":"10.1001\/archneur.64.5.706"},{"key":"833_CR94","first-page":"304","volume":"15","author":"KY Chan","year":"2009","unstructured":"Chan KY, Ching CK, Mak CM, Lam CW, Chan AYW (2009) Hereditary spastic paraplegia: identification of an SPG3A gene mutation in a Chinese family. Hong Kong Med J 15:304\u2013307","journal-title":"Hong Kong Med J"},{"key":"833_CR95","doi-asserted-by":"crossref","unstructured":"Alvarez V, S\u00e1nchez-Ferrero E, Beetz C, D\u00edaz M, Alonso B, Corao AI et al (2010) Mutational spectrum of the SPG4 (SPAST) and SPG3A (ATL1) genes in Spanish patients with hereditary spastic paraplegia. BMC Neurol 10:89. https:\/\/doi.10.1186\/1471-2377-10-89","DOI":"10.1186\/1471-2377-10-89"},{"key":"833_CR96","first-page":"375","volume":"40","author":"M-J Kwon","year":"2010","unstructured":"Kwon M-J, Lee S-T, Kim J-W, Sung DH, Ki C-S (2010) Clinical and genetic analysis of a Korean family with hereditary spastic paraplegia type 3. Ann Clin Lab Sci 40:375\u2013379","journal-title":"Ann Clin Lab Sci"},{"key":"833_CR97","doi-asserted-by":"crossref","unstructured":"McCorquodale DS, Ozomaro U, Huang J, Montenegro G, Kushman A, Citrigno L et al (2011) Mutation screening of spastin, atlastin, and REEP1 in hereditary spastic paraplegia. Clin Genet 79:523\u2013530. https:\/\/doi.10.1111\/j.1399-0004.2010.01501.x","DOI":"10.1111\/j.1399-0004.2010.01501.x"},{"key":"833_CR98","doi-asserted-by":"crossref","unstructured":"Terada T, Kono S, Ouchi Y, Yoshida K, Hamaya Y, Kanaoka S et al (2013) SPG3A-linked hereditary spastic paraplegia associated with cerebral glucose hypometabolism. Ann Nucl Med 27:303\u2013308. https:\/\/doi.10.1007\/s12149-012-0673-5","DOI":"10.1007\/s12149-012-0673-5"},{"key":"833_CR99","doi-asserted-by":"crossref","unstructured":"Leonardi L, Marcotulli C, Santorelli FM, Tessa A, Casali C (2015) De novo mutations in SPG3A: a challenge in differential diagnosis and genetic counselling. Neurol Sci 36:1063\u20131064. https:\/\/doi.10.1007\/s10072-015-2097-1","DOI":"10.1007\/s10072-015-2097-1"},{"key":"833_CR100","doi-asserted-by":"crossref","unstructured":"Hsu S-L, Hsueh H-W, Chen S-Y, Chang Y-Y, Tan S, Hong C-T et al (2021) Clinical and genetic characterization of hereditary spastic paraplegia type 3A in Taiwan. Parkinsonism Relat Disord 87:87\u201391. https:\/\/doi.10.1016\/j.parkreldis.2021.05.004","DOI":"10.1016\/j.parkreldis.2021.05.004"},{"key":"833_CR101","unstructured":"Hedera P (2020) Spastic Paraplegia 3A., In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, Gripp KW, Amemiya A, editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK45978\/ [Accessed February 26, 2024]"},{"key":"833_CR102","unstructured":"Parodi L, Rydning SL, Tallaksen C, Durr A (2019) Spastic Paraplegia 4., In: Adam MP, Feldman J, Mirzaa GM, Pagon RA, Wallace SE, Bean LJ, Gripp KW, Amemiya A, editors. GeneReviews\u00ae. Seattle (WA): University of Washington, Seattle http:\/\/www.ncbi.nlm.nih.gov\/books\/NBK1160\/ [Accessed May 24, 2024]"},{"key":"833_CR103","doi-asserted-by":"crossref","unstructured":"Solowska JM, Baas PW (2015) Hereditary spastic paraplegia SPG4: What is known and not known about the disease. Brain 138:2471\u20132484. https:\/\/doi.10.1093\/brain\/awv178","DOI":"10.1093\/brain\/awv178"},{"key":"833_CR104","doi-asserted-by":"crossref","unstructured":"de Bot ST, van den Elzen RTM, Mensenkamp AR, Schelhaas HJ, Willemsen M a. a., Knoers P et al (2010) NV a. M, Hereditary spastic paraplegia due to SPAST mutations in 151 Dutch patients: new clinical aspects and 27 novel mutations. J Neurol Neurosurg Psychiatry 81:1073\u20131078. https:\/\/doi.10.1136\/jnnp.2009.201103","DOI":"10.1136\/jnnp.2009.201103"},{"key":"833_CR105","doi-asserted-by":"crossref","unstructured":"Cruz-Camino H, V\u00e1zquez-Cant\u00fa M, V\u00e1zquez-Cant\u00fa DL, Santos-Guzm\u00e1n J, Bandala-Jacques A, G\u00f3mez-Guti\u00e9rrez R et al (2020) Clinical Characterization of 2 Siblings with a Homozygous SPAST Variant. Am J Case Rep 21:e919463. https:\/\/doi.10.12659\/AJCR.919463","DOI":"10.12659\/AJCR.919463"},{"key":"833_CR106","doi-asserted-by":"crossref","unstructured":"Varghaei P, Estiar MA, Ashtiani S, Veyron S, Mufti K, Leveille E et al (2022) Genetic, structural and clinical analysis of spastic paraplegia 4. Parkinsonism Relat Disord 98:62\u201369. https:\/\/doi.10.1016\/j.parkreldis.2022.03.019","DOI":"10.1016\/j.parkreldis.2022.03.019"},{"key":"833_CR107","doi-asserted-by":"crossref","unstructured":"Coutelier M, Goizet C, Durr A, Habarou F, Morais S, Dionne-Laporte A et al (2015) Alteration of ornithine metabolism leads to dominant and recessive hereditary spastic paraplegia. Brain 138:2191\u20132205. https:\/\/doi.10.1093\/brain\/awv143","DOI":"10.1093\/brain\/awv143"},{"key":"833_CR108","doi-asserted-by":"crossref","unstructured":"Alazami AM, Adly N, Al Dhalaan H, Alkuraya FS (2011) A nullimorphic ERLIN2 mutation defines a complicated hereditary spastic paraplegia locus (SPG18). Neurogenetics 12:333\u2013336. https:\/\/doi.10.1007\/s10048-011-0291-8","DOI":"10.1007\/s10048-011-0291-8"},{"key":"833_CR109","doi-asserted-by":"crossref","unstructured":"Rydning SL, Dudesek A, Rimmele F, Funke C, Kr\u00fcger S, Biskup S et al (2018) A novel heterozygous variant in ERLIN2 causes autosomal dominant pure hereditary spastic paraplegia. Eur J Neurol 25:943-e71. https:\/\/doi.10.1111\/ene.13625","DOI":"10.1111\/ene.13625"},{"key":"833_CR110","doi-asserted-by":"crossref","unstructured":"Klebe S, Lossos A, Azzedine H, Mundwiller E, Sheffer R, Gaussen M et al (2012) KIF1A missense mutations in SPG30, an autosomal recessive spastic paraplegia: distinct phenotypes according to the nature of the mutations. Eur J Hum Genet 20:645\u2013649. https:\/\/doi.10.1038\/ejhg.2011.261","DOI":"10.1038\/ejhg.2011.261"},{"key":"833_CR111","doi-asserted-by":"crossref","unstructured":"Cheon CK, Lim S-H, Kim Y-M, Kim D, Lee N-Y, Yoon T-S et al (2017) Autosomal dominant transmission of complicated hereditary spastic paraplegia due to a dominant negative mutation of KIF1A, SPG30 gene. Sci Rep 7:12527. https:\/\/doi.10.1038\/s41598-017-12999-9","DOI":"10.1038\/s41598-017-12999-9"},{"key":"833_CR112","doi-asserted-by":"crossref","unstructured":"Esteves T, Durr A, Mundwiller E, Loureiro JL, Boutry M, Gonzalez MA et al (2014) Loss of association of REEP2 with membranes leads to hereditary spastic paraplegia. Am J Hum Genet 94:268\u2013277. https:\/\/doi.10.1016\/j.ajhg.2013.12.005","DOI":"10.1016\/j.ajhg.2013.12.005"},{"key":"833_CR113","doi-asserted-by":"crossref","unstructured":"Khan TN, Klar J, Tariq M, Anjum Baig S, Malik NA, Yousaf R et al (2014) Evidence for autosomal recessive inheritance in SPG3A caused by homozygosity for a novel ATL1 missense mutation. Eur J Hum Genet 22:1180\u20131184. https:\/\/doi.10.1038\/ejhg.2014.5","DOI":"10.1038\/ejhg.2014.5"},{"key":"833_CR114","doi-asserted-by":"crossref","unstructured":"Willkomm L, Heredia R, Hoffmann K, Wang H, Voit T, Hoffman EP et al (2016) Homozygous mutation in Atlastin GTPase 1 causes recessive hereditary spastic paraplegia. J Hum Genet 61:571\u2013573. https:\/\/doi.10.1038\/jhg.2016.6","DOI":"10.1038\/jhg.2016.6"},{"key":"833_CR115","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-Ferrero E, Coto E, Beetz C, G\u00e1mez J, Corao AI, D\u00edaz M et al (2013) SPG7 mutational screening in spastic paraplegia patients supports a dominant effect for some mutations and a pathogenic role for p.A510V. Clin Genet 83:257\u2013262. https:\/\/doi.10.1111\/j.1399-0004.2012.01896.x","DOI":"10.1111\/j.1399-0004.2012.01896.x"},{"key":"833_CR116","doi-asserted-by":"crossref","unstructured":"Ramirez A, Heimbach A, Gr\u00fcndemann J, Stiller B, Hampshire D, Cid LP et al (2006) Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase. Nat Genet 38:1184\u20131191. https:\/\/doi.10.1038\/ng1884","DOI":"10.1038\/ng1884"},{"key":"833_CR117","doi-asserted-by":"crossref","unstructured":"Bras J, Verloes A, Schneider SA, Mole SE, Guerreiro RJ (2012) Mutation of the parkinsonism gene ATP13A2 causes neuronal ceroid-lipofuscinosis. Hum Mol Genet 21:2646\u20132650. https:\/\/doi.10.1093\/hmg\/dds089","DOI":"10.1093\/hmg\/dds089"},{"key":"833_CR118","doi-asserted-by":"crossref","unstructured":"Estrada-Cuzcano A, Martin S, Chamova T, Synofzik M, Timmann D, Holemans T et al (2017) Loss-of-function mutations in the ATP13A2\/PARK9 gene cause complicated hereditary spastic paraplegia (SPG78). Brain 140:287\u2013305. https:\/\/doi.10.1093\/brain\/aww307","DOI":"10.1093\/brain\/aww307"},{"key":"833_CR119","doi-asserted-by":"crossref","unstructured":"Erro R, Picillo M, Manara R, Pellecchia MT, Barone P (2019) From PARK9 to SPG78: The clinical spectrum of ATP13A2 mutations. Parkinsonism Relat Disord 65:272\u2013273. https:\/\/doi.10.1016\/j.parkreldis.2019.05.025","DOI":"10.1016\/j.parkreldis.2019.05.025"},{"key":"833_CR120","doi-asserted-by":"crossref","unstructured":"Miranda M, Harmuth F, Bustamante ML, Rossi M, Sturm M, Magnusson \u00d3T et al (2020) Intermediate phenotype of ATP13A2 mutation in two Chilean siblings: Towards a continuum between parkinsonism and hereditary spastic paraplegia. Parkinsonism Relat Disord 81:45\u201347. https:\/\/doi.10.1016\/j.parkreldis.2020.10.004","DOI":"10.1016\/j.parkreldis.2020.10.004"},{"key":"833_CR121","doi-asserted-by":"crossref","unstructured":"Novarino G, Fenstermaker AG, Zaki MS, Hofree M, Silhavy JL, Heiberg AD et al (2014) Exome sequencing links corticospinal motor neuron disease to common neurodegenerative disorders. Science (New York, NY) 343:506. https:\/\/doi.10.1126\/science.1247363","DOI":"10.1126\/science.1247363"},{"key":"833_CR122","doi-asserted-by":"crossref","unstructured":"Kamate M, Detroja M (2019) Clinico-investigative profile of hereditary spastic paraplegia in children. Ann Indian Acad Neurol 22:341\u2013344. https:\/\/doi.10.4103\/aian.AIAN_527_18","DOI":"10.4103\/aian.AIAN_527_18"},{"key":"833_CR123","doi-asserted-by":"crossref","unstructured":"Liu Y-T, Lee Y-C, Soong B-W (2015) What we have learned from the next-generation sequencing: Contributions to the genetic diagnoses and understanding of pathomechanisms of neurodegenerative diseases. Journal of Neurogenetics 29:103\u2013112. https:\/\/doi.10.3109\/01677063.2015.1060972","DOI":"10.3109\/01677063.2015.1060972"},{"key":"833_CR124","doi-asserted-by":"crossref","unstructured":"Hensiek A, Kirker S, Reid E (2015) Diagnosis, investigation and management of hereditary spastic paraplegias in the era of next-generation sequencing. J Neurol 262:1601\u20131612. https:\/\/doi.10.1007\/s00415-014-7598-y","DOI":"10.1007\/s00415-014-7598-y"},{"key":"833_CR125","doi-asserted-by":"crossref","unstructured":"Bis-Brewer DM, Z\u00fcchner S (2018) Perspectives on the genomics of HSP beyond mendelian inheritance. Front Neurol 9:958. https:\/\/doi.10.3389\/fneur.2018.00958","DOI":"10.3389\/fneur.2018.00958"}],"container-title":["Neurogenetics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00833-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10048-025-00833-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10048-025-00833-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,26]],"date-time":"2026-01-26T04:06:10Z","timestamp":1769400370000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10048-025-00833-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,25]]},"references-count":125,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["833"],"URL":"https:\/\/doi.org\/10.1007\/s10048-025-00833-8","relation":{},"ISSN":["1364-6753"],"issn-type":[{"value":"1364-6753","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,25]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All procedures performed in human participants were done in accordance with the ethical agreement of the Mustapha Hospital ethics committee (n\u00b0 17\/CE\/2025) and followed the 1964 Helsinki Declaration and its later amendments.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Informed written consent from all human subjects or their legal guardians, have been obtained prior to clinical examination and blood sampling, allowing the genetic testing and use of the data for scientific publication.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Informed written consent from all human subjects or their legal guardians, have been obtained prior to clinical examination and blood sampling, allowing the genetic testing and use of the data for scientific publication.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed consent"}},{"value":"GS received a grant from Biogen, unrelated to this study from 2019 to 2023. All other authors have no relevant financial or non-financial interests to disclose.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"52"}}